2015-07-01 | Sale | Amicus Therapeutics, Inc. FOLD | SVP, Chief Patient Advocate | 21,298 0.0179% | $13.97 | $297,635 | -43.01% | |
2015-05-11 | Sale | Amicus Therapeutics, Inc. FOLD | SVP, Chief Patient Advocate | 20,000 0.0201% | $10.84 | $216,778 | -10.41% | |
2015-03-20 | Sale | Amicus Therapeutics, Inc. FOLD | VP, Patient Advocacy | 21,296 0.0221% | $11.51 | $245,136 | -7.32% | |
2014-08-27 | Sale | Amicus Therapeutics, Inc. FOLD | VP, Patient Advocacy | 10,000 0.0096% | $5.16 | $51,600 | +27.92% | |
2014-08-27 | Amicus Therapeutics, Inc. FOLD | VP, Patient Advocacy | 10,000 0.0096% | $5.16 | $51,600 | +27.92% | ||
2014-08-25 | Sale | Amicus Therapeutics, Inc. FOLD | VP, Patient Advocacy | 10,000 0.0098% | $4.66 | $46,600 | +45.09% | |
2014-08-25 | Amicus Therapeutics, Inc. FOLD | VP, Patient Advocacy | 10,000 0.0098% | $4.66 | $46,600 | +45.09% | ||
2014-08-20 | Sale | Amicus Therapeutics, Inc. FOLD | VP, Patient Advocacy | 12,160 0.0115% | $4.11 | $49,917 | +57.27% | |
2014-08-20 | Amicus Therapeutics, Inc. FOLD | VP, Patient Advocacy | 12,160 0.0115% | $4.11 | $49,917 | +57.27% |